Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies

NCT03593421 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped BioInceptdecided not to pursue this drug target at this time.

Conditions

Panel Reactive Antibodies

Interventions

DRUG: synthetic PreImplantation Factor

Sponsor

Christopher O'Brien, MD

Collaborators

[object Object]